Bessemer Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$169M Sell
2,165,359
-2,587,971
-54% -$209M 0.23% 112
2026
Q1
$412M Buy
4,753,330
+677,343
+17% +$64.9M 0.65% 26
2025
Q4
$392M Buy
4,075,987
+1,537,958
+61% +$149M 0.6% 30
2025
Q3
$242M Buy
2,538,029
+1,174,765
+86% +$108M 0.37% 63
2025
Q2
$119M Buy
1,363,264
+326,117
+31% +$27.7M 0.19% 134
2025
Q1
$93.2M Buy
1,037,147
+371,539
+56% +$33.2M 0.17% 144
2024
Q4
$53.2M Sell
665,608
-13,561
-2% -$1.17M 0.09% 181
2024
Q3
$61.1M Buy
679,169
+1,434
+0.2% +$121K 0.1% 173
2024
Q2
$53.3M Sell
677,735
-12,183
-2% -$999K 0.09% 185
2024
Q1
$60.1M Buy
689,918
+2,462
+0.4% +$210K 0.11% 186
2023
Q4
$56.6M Buy
687,456
+7,002
+1% +$534K 0.11% 188
2023
Q3
$53.3M Sell
680,454
-420,225
-38% -$35.2M 0.12% 180
2023
Q2
$97M Buy
1,100,679
+16,789
+2% +$1.45M 0.21% 136
2023
Q1
$87.4M Buy
1,083,890
+312,554
+41% +$25.5M 0.21% 139
2022
Q4
$59.9M Buy
771,336
+6,493
+0.8% +$526K 0.15% 164
2022
Q3
$61.8M Sell
764,843
-197,215
-20% -$17.7M 0.16% 159
2022
Q2
$86.3M Buy
962,058
+29,648
+3% +$3M 0.22% 138
2022
Q1
$103M Buy
932,410
+12,458
+1% +$1.32M 0.22% 134
2021
Q4
$95.2M Buy
919,952
+14,732
+2% +$1.71M 0.19% 145
2021
Q3
$113M Buy
905,220
+5,794
+0.6% +$750K 0.24% 135
2021
Q2
$112M Buy
899,426
+33,062
+4% +$4.15M 0.24% 136
2021
Q1
$102M Buy
866,364
+45,086
+5% +$5.28M 0.25% 129
2020
Q4
$96.2M Buy
821,278
+5,284
+0.6% +$582K 0.25% 117
2020
Q3
$84.8M Buy
815,994
+108,938
+15% +$10.9M 0.25% 109
2020
Q2
$64.8M Buy
707,056
+1,768
+0.3% +$170K 0.2% 121
2020
Q1
$63.6M Buy
705,288
+8,153
+1% +$867K 0.26% 109
2019
Q4
$79.1M Sell
697,135
-20,777
-3% -$2.28M 0.26% 109
2019
Q3
$78M Buy
717,912
+1,423
+0.2% +$148K 0.28% 108
2019
Q2
$69.8M Buy
716,489
+6,340
+0.9% +$579K 0.24% 125
2019
Q1
$64.7M Buy
710,149
+13,485
+2% +$1.21M 0.25% 125
2018
Q4
$63.4M Buy
696,664
+681,539
+4,506% +$63.7M 0.28% 108
2018
Q3
$1.49M Sell
15,125
-1,844
-11% -$170K 0.01% 487
2018
Q2
$1.45M Sell
16,969
-10,077
-37% -$842K 0.01% 476
2018
Q1
$2.17M Buy
27,046
+5,868
+28% +$484K 0.01% 391
2017
Q4
$1.71M Sell
21,178
-4,248
-17% -$340K 0.01% 452
2017
Q3
$1.98M Sell
25,426
-1,819
-7% -$151K 0.01% 441
2017
Q2
$2.42M Sell
27,245
-885
-3% -$74.6K 0.01% 412
2017
Q1
$2.27M Buy
28,130
+886
+3% +$69.2K 0.01% 467
2016
Q4
$1.94M Sell
27,244
-561,927
-95% -$44.1M 0.01% 528
2016
Q3
$50.9M Sell
589,171
-491,096
-45% -$42.8M 0.26% 122
2016
Q2
$93.7M Sell
1,080,267
-653,969
-38% -$52.9M 0.51% 74
2016
Q1
$130M Sell
1,734,236
-341,622
-16% -$25.7M 0.73% 33
2015
Q4
$160M Buy
2,075,858
+15,229
+0.7% +$1.15M 0.89% 29
2015
Q3
$138M Sell
2,060,629
-279,929
-12% -$20.6M 0.79% 37
2015
Q2
$173M Sell
2,340,558
-227,814
-9% -$17.4M 0.91% 27
2015
Q1
$200M Buy
2,568,372
+706,409
+38% +$53.5M 1.02% 24
2014
Q4
$134M Buy
1,861,963
+342,017
+23% +$23.8M 0.72% 39
2014
Q3
$94.2M Sell
1,519,946
-44,440
-3% -$2.83M 0.53% 69
2014
Q2
$99.7M Buy
1,564,386
+641,647
+70% +$39M 0.61% 59
2014
Q1
$56.8M Buy
922,739
+884,463
+2,311% +$51.5M 0.38% 107
2013
Q4
$2.2M Buy
38,276
+18,640
+95% +$1.06M 0.02% 335
2013
Q3
$1.05M Sell
19,636
-500
-2% -$26.9K 0.01% 408
2013
Q2
$1.04M Buy
+20,136
New +$995K 0.01% 388

Other funds holding MDT

Bessemer Group's MDT Position: Q2 2026 in Review

Bessemer Group reduced its Medtronic (MDT) stake by 54% in Q2 2026, selling an estimated $209M and leaving 2,165,359 shares worth $169M. The position accounts for 0.23% of the portfolio, ranked #112.

Bessemer Group first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $412M in Q1 2026. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Bessemer Group held 2,165,359 shares of Medtronic worth $169M as of Q2 2026.
  • Bessemer Group sold 2,587,971 Medtronic shares in Q2 2026, an estimated $209M.
  • Medtronic made up 0.23% of Bessemer Group's portfolio in Q2 2026, its #112 holding.
  • Bessemer Group first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Bessemer Group's Medtronic position peaked at $412M in Q1 2026.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.